DHG Pharmaceutical JSC (HOSE:DHG)

Vietnam · Delayed Price · Currency is VND

90,900

+700 (0.78%)

At close: Jul 24, 2026

-12.09% (1Y)

Market Cap	11.88T -12.1%
Revenue (ttm)	5.45T +11.2%
Net Income	932.66B +11.1%
EPS	7,133.35 +11.2%
Shares Out	130.75M
PE Ratio	12.74
Forward PE	12.80
Dividend	5,000.00 (5.54%)
Ex-Dividend Date	May 11, 2026

Volume	8,913
Open	90,500
Previous Close	90,200
Day's Range	90,000 - 91,000
52-Week Range	89,900 - 110,000
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceutical... [Read more]

Industry Pharmaceutical Preparations

Founded 1974

Employees 2,806

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol DHG

Full Company Profile

Financial Performance

In 2025, DHG Pharmaceutical JSC's revenue was 5.27 trillion, an increase of 7.82% compared to the previous year's 4.88 trillion. Earnings were 824.78 billion, an increase of 9.45%.

Financial Statements